Antisense Therapeutics Limited
ASX:ANP.AX
0.058 (AUD) • At close January 3, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) AUD.
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 1.58 | 1.778 | 0.578 | 0.668 | 0.587 | 0 | 0.069 | 1 | 3.864 | 0 | 0 | 0 | 0 | 0 | 0 | 6.399 | 0.762 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue
| 0.033 | 0.066 | 0.11 | 0.204 | 0.138 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit
| 1.547 | 1.712 | 0.467 | 0.465 | 0.449 | 0 | 0.069 | 1 | 3.864 | 0 | 0 | 0 | 0 | 0 | 0 | 6.399 | 0.762 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit Ratio
| 0.979 | 0.963 | 0.809 | 0.695 | 0.765 | 0 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 10.162 | 4.535 | 4.913 | 1.899 | 1.761 | 0.975 | 1.104 | 1.848 | 1.676 | 2.146 | 1.546 | 1.115 | 0.647 | 1.488 | 1.849 | 5.132 | 3.373 | 2.987 | 4.474 | 3.823 | 3.729 | 5.132 | 0.235 |
| General & Administrative Expenses
| 3.054 | 2.921 | 3.556 | 4.456 | 1.679 | 1.428 | 1.975 | 1.908 | 2 | 1.946 | 1.984 | 1.563 | 1.635 | 2.233 | 2.548 | 2.287 | 1.577 | 1.289 | 1.268 | 1.182 | 1.518 | 0.806 | 0.022 |
| Selling & Marketing Expenses
| 1.323 | 1.142 | 0.836 | 0.628 | 0.373 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.147 | 0.144 | 0.194 | 0.092 | 0 | 0 | 0.095 | 0.04 | 0 | 0 | 0.001 |
| SG&A
| 3.054 | 2.921 | 3.556 | 4.456 | 1.679 | 1.428 | 1.975 | 1.908 | 2 | 1.946 | 1.984 | 1.563 | 1.635 | 2.233 | 2.548 | 2.287 | 1.577 | 1.289 | 1.268 | 1.182 | 1.518 | 0.806 | 0.022 |
| Other Expenses
| 1.588 | 0.155 | 0.214 | 0.311 | 0.143 | 0.264 | 0.392 | 0.426 | 0.679 | 1.16 | 1.104 | 0.958 | 0.531 | 0.322 | 0.44 | 0.167 | 0.279 | 0.076 | 0.275 | 0.668 | 0.002 | 0.783 | -0.133 |
| Operating Expenses
| 13.345 | 7.611 | 8.683 | 6.666 | 3.583 | 2.62 | 3.287 | 4.072 | 3.889 | 4.256 | 3.762 | 2.861 | 2.435 | 3.871 | 4.599 | 7.52 | 5.598 | 5.947 | 7.135 | 6.344 | 6.568 | 6.731 | 0.272 |
| Operating Income
| -13.345 | -7.611 | -8.683 | -6.666 | -3.583 | -2.62 | -3.218 | -3.072 | -0.025 | -4.256 | -3.762 | -2.861 | -2.435 | -3.871 | -4.599 | -1.121 | -5.602 | -5.947 | -7.135 | -6.344 | -6.573 | -6.721 | -0.272 |
| Operating Income Ratio
| -8.447 | -4.281 | -15.029 | -9.973 | -6.106 | 0 | -46.554 | -3.072 | -0.006 | 0 | 0 | 0 | 0 | 0 | 0 | -0.175 | -7.348 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| 1.588 | 1.799 | 0.623 | 0.758 | 0.639 | 0.264 | 0.392 | 0.426 | 0.679 | 1.16 | 1.104 | 0.958 | 0.531 | 0.322 | 0.44 | 0.167 | 0.279 | 0.076 | 0.275 | 0.668 | -0.004 | 0.4 | -0.133 |
| Income Before Tax
| -11.38 | -5.812 | -8.061 | -5.908 | -2.944 | -2.331 | -2.755 | -2.514 | 0.707 | -3.013 | -2.455 | -1.801 | -1.814 | -3.446 | -3.904 | -0.537 | -4.836 | -5.462 | -6.266 | -4.981 | -6.108 | -6.321 | -0.394 |
| Income Before Tax Ratio
| -7.203 | -3.269 | -13.951 | -8.839 | -5.018 | 0 | -39.858 | -2.514 | 0.183 | 0 | 0 | 0 | 0 | 0 | 0 | -0.084 | -6.343 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Tax Expense
| -0.377 | 0.022 | 0.007 | -0.018 | -0.639 | 0.289 | -0.071 | -0.132 | -0.052 | -0.083 | -0.203 | -0.102 | -0.091 | -0.021 | -1.254 | 1.6 | 0.279 | -0.408 | -6.266 | -4.981 | -6.108 | -6.321 | -0.394 |
| Net Income
| -11.38 | -5.834 | -8.067 | -5.89 | -2.306 | -2.331 | -2.755 | -2.514 | 0.707 | -3.013 | -2.455 | -1.801 | -1.814 | -3.425 | -2.65 | -2.137 | -4.836 | -5.462 | -6.266 | -4.61 | -6.108 | -6.321 | -0.394 |
| Net Income Ratio
| -7.203 | -3.281 | -13.963 | -8.812 | -3.93 | 0 | -39.858 | -2.514 | 0.183 | 0 | 0 | 0 | 0 | 0 | 0 | -0.334 | -6.343 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS
| -0.018 | -0.009 | -0.015 | -0.013 | -0.006 | -0.012 | -0.017 | -0.014 | 0.004 | -0.021 | -0.017 | -0.017 | -0.024 | -0.038 | -0.03 | -0.026 | -0.062 | -0.1 | -0.12 | -0.089 | -0.16 | -0.25 | -0.012 |
| EPS Diluted
| -0.018 | -0.009 | -0.015 | -0.013 | -0.006 | -0.012 | -0.017 | -0.014 | 0.004 | -0.021 | -0.017 | -0.017 | -0.024 | -0.038 | -0.03 | -0.026 | -0.062 | -0.1 | -0.12 | -0.089 | -0.16 | -0.25 | -0.012 |
| EBITDA
| -13.25 | -7.522 | -8.58 | -6.559 | -3.578 | -2.614 | -3.213 | -3.067 | -0.017 | -4.246 | -3.754 | -2.854 | -2.429 | -3.864 | -4.591 | -1.112 | -4.375 | -4.492 | -5.837 | -5.045 | -4.805 | -5.634 | -0.271 |
| EBITDA Ratio
| -8.387 | -4.231 | -14.85 | -9.812 | -6.097 | 0 | -46.484 | -3.067 | -0.004 | 0 | 0 | 0 | 0 | 0 | 0 | -0.174 | -5.739 | 0 | 0 | 0 | 0 | 0 | 0 |